[ad_1] Revenue of the US pharmaceutical company Gilead Sciences increased 17% in the third quarter, supported by sales of the antiviral drug remdesivir, the first and only officially approved treatment by the United States for the treatment of hospitalized patients with Covid-19, Reuters reports. Read also: Adriana Săftoiu SPRAY NLP …
Read More »Pandemic enrichment: the company that produces Remdesivir, earns RECORD – News by sources
